OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
32
Results
Show all
Save search
Copy query
Show results for
Unknown
(32)
Publication Date
Release Date
2021
(8)
2022
(6)
2025
(4)
2023
(4)
2024
(2)
2015
(2)
2009
(2)
2020
(1)
2017
(1)
2016
(1)
2014
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics.
Not available
S-EPMC5576574
|
biostudies-literature
Cite
Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement.
Not available
S-EPMC9034687
|
biostudies-literature
Cite
A global reference for human genetic variation.
Not available
S-EPMC4750478
|
biostudies-literature
Cite
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study.
Not available
S-EPMC7906670
|
biostudies-literature
Cite
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic.
Not available
S-EPMC10364875
|
biostudies-literature
Cite
New insights into the genetic etiology of Alzheimer's disease and related dementias.
Not available
S-EPMC9005347
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets